STOCK TITAN

Issuer (NASDAQ: REGN) Form 144 covers planned sale of 400 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A person associated with the issuer has filed a Form 144 to potentially sell 400 shares of common stock through J.P. Morgan Securities LLC on or about 02/09/2026 on NASDAQ. The filing lists an aggregate market value of 314204 for these shares and notes that 103902660 shares of this class were outstanding. The 400 shares were originally acquired on 08/22/2013 from the issuer as compensation.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the REGN Form 144 filing disclose about planned share sales?

The Form 144 filing discloses a planned sale of 400 common shares. These shares are to be sold through J.P. Morgan Securities LLC on or about February 9, 2026 on NASDAQ, with an aggregate market value listed as 314204.

How many REGN shares are covered and what is their aggregate market value?

The notice covers 400 shares of common stock with an aggregate market value of 314204. This value comes directly from the Form 144 table describing the number of units to be sold and their total market value at the time of the filing.

When were the REGN shares in this Form 144 originally acquired and how?

The 400 common shares were acquired on 08/22/2013 as compensation from the issuer. The filing states the nature of the acquisition transaction as “Compensation” and lists the issuer as the source of the shares.

What does the Form 144 say about REGN shares outstanding?

The filing reports 103902660 shares of the issuer’s common stock outstanding. This figure appears in the securities information table and serves as a baseline context for the planned sale of 400 shares.

Which broker is handling the planned REGN share sale in this Form 144?

The planned sale is to be handled by J.P. Morgan Securities LLC. The broker’s address is listed as 270 Park Avenue, 10th Floor, New York, NY 10017, and the transaction is noted as taking place on NASDAQ.

What representation does the seller make in the REGN Form 144 filing?

The seller represents that they do not know any undisclosed material adverse information about the issuer. By signing, they also acknowledge that intentional misstatements or omissions can constitute federal criminal violations under 18 U.S.C. 1001.
Regeneron Pharmaceuticals

NASDAQ:REGN

REGN Rankings

REGN Latest News

REGN Latest SEC Filings

REGN Stock Data

83.04B
101.07M
1.93%
90.21%
2.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
TARRYTOWN